Evidence map›Paper›PMID 15619624›Full record

ArticleNature immunology2005

Epigenetic ontogeny of the Igk locus during B cell development.

Maya Goldmit, Yanhong Ji, Jane Skok, Esther Roldan, Steffen Jung, Howard Cedar, Yehudit Bergman

Abstract read
PubMed Publisher
In one paragraph

Article in Nature immunology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 160 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. TargetingFrontiers in immunology · 2021
    Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. H3K4me3 induces allosteric conformational changes in the DNA-binding and catalytic regions of the V(D)J recombinase.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  17. Article
  18. Article
  19. Review
  20. Article

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Maya GoldmitDepartment of Experimental Medicine, Hebrew University Medical School, Jerusalem 91120, Israel.
Yanhong Ji
Jane Skok
Esther Roldan
Steffen Jung
Howard Cedar
Yehudit Bergman
Hebrew University of Jerusalem · ILUniversity College London · GBWeizmann Institute of Science · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To become accessible for rearrangement, the immunoglobulin kappa locus must undergo a series of epigenetic changes. This begins in pro-B cells with the relocation of both immunoglobulin kappa alleles from the periphery to the center of the nucleus. In pre-B cells, one allele became preferentially packaged into an active chromatin structure characterized by histone acetylation and methylation of histone H3 lysine 4, while the other allele was recruited to heterochromatin, where it was associated with heterochromatin protein-gamma and Ikaros. These events in cis made only one allele accessible to trans-acting factors, such as RelB, which mediated DNA demethylation, to facilitate rearrangement. These results suggest that early B lymphoid epigenetic changes generate differential structures that serve as the basis for allelic exclusion.

Indexed as

Cell DifferentiationAllelesAnimalsB-LymphocytesCell NucleusCells, CulturedDNADNA-Binding ProteinsDNA MethylationHeterochromatinHistonesIkaros Transcription FactorImmunoglobulinsMiceProto-Oncogene ProteinsTranscription Factor RelBDNADNA-Binding ProteinsHeterochromatinHistonesIgKIkaros Transcription FactorImmunoglobulinsProto-Oncogene ProteinsRelb protein, mouseTranscription Factor RelBTranscription FactorsZfpn1a1 protein, mouse

Identifiers

PMID15619624
OpenAlexW2123431252

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.